Pharmacology In Drug Discovery And Development May 2026

As the industry moves toward complex modalities—antibody-drug conjugates, RNA therapeutics, gene editing, and PROTACs—the principles of pharmacology remain unchanged. What is the target? How does the drug reach it? What does the body do to the drug? And most importantly, what is the therapeutic index in humans?

This article dissects the multifaceted role of pharmacology across the entire value chain of drug creation, from target identification to post-marketing surveillance. Before a single compound is synthesized, pharmacology asks the most critical question: Is this target druggable? Defining the Biological Target Drug discovery begins with a disease hypothesis. Pharmacology steps in to validate the biological target—typically a receptor, enzyme, ion channel, or nucleic acid. Using tools like CRISPR-Cas9, RNA interference, and monoclonal antibodies, pharmacologists confirm that modulating this target will indeed produce a therapeutic effect. pharmacology in drug discovery and development

Answering those questions with rigor and creativity is not just a job for pharmacologists. It is the solemn responsibility of everyone involved in turning molecules into medicines. References available upon request. For further reading, consult "Goodman & Gilman's The Pharmacological Basis of Therapeutics" and the FDA's "Guidance for Industry: Clinical Pharmacology." What does the body do to the drug